The PedAL (Pediatric Acute Leukemia) Master Trial is at the heart of LLS's Dare to Dream Project to transform treatment and care for kids with blood cancer Infants and children with specific types ...

12, 2024 — Scientists have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.

A Tapestry high school senior never imagined his senior year would be interrupted by a cancer diagnosis. Dakarai Jackson Jr.

New markers of treatment resistance or toxicity are needed in pediatric acute lymphoblastic leukemia (ALL). Pharmacogenetic studies can be useful for childhood ALL because treatment protocols are ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...

Survival rates for childhood leukemia are improving thanks to new treatments. Acute lymphoblastic leukemia has the highest survival among all pediatric cancers, 80-85 percent. Seattle Children’s ...

The funds will be used for pediatric cancer immunology research. "It is going to open up avenues for us to help more children ...